This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Carville SF et al. (2008) EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis 67: 536–541
O'Malley PG et al. (2000) Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med 15: 659–666
Fishbain D (2000) Evidence-based data on pain relief with antidepressants. Ann Med 32: 305–316
Lautenbacher S and Rollman GB (1997) Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13: 189–196
Kosek E and Hansson P (1997) Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70: 41–51
Wood PB et al. (2007) Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci 25: 3576–3582
Sarchielli P et al. (2007) Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11: 343–351
Skrabek RQ et al. (2008) Nabilone for the treatment of pain in fibromyalgia. J Pain 9: 164–173
Baraniuk JN et al. (2004) Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord 5: 48
Harris RE et al. (2007) Decreased central µ-opioid receptor availability in fibromyalgia. J Neurosci 27: 10000–10006
Moldofsky H et al. (1975) Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 37: 341–351
Gracely RH et al. (2004) Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127: 835–843
Author information
Authors and Affiliations
Ethics declarations
Competing interests
DJ Clauw has acted as a consultant for Cypress, Forest, Lilly, Pfizer and Wyeth.
Rights and permissions
About this article
Cite this article
Clauw, D. Commentary on the EULAR recommendations for the management of fibromyalgia. Nat Rev Rheumatol 4, 392–393 (2008). https://doi.org/10.1038/ncprheum0840
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0840